Erectile Dysfunction: Causes, Evaluation, and Treatment Options in Florida
Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for sexual activity. While it can become more common with age, it is not simply an inevitable part of getting older.
ED can be an early sign of an underlying health concern, particularly cardiovascular disease, diabetes, or metabolic dysfunction. Identifying the cause is an important first step toward
choosing an appropriate treatment.
What Causes Erectile Dysfunction?
An erection depends on healthy blood flow, functioning nerves, appropriate hormone levels, and psychological factors. Problems in any of these areas can contribute to ED.
Cardiovascular disease and poor circulation
High blood pressure, elevated cholesterol, atherosclerosis, and vascular disease can impair blood flow to the penis. Because the penile arteries are smaller than coronary arteries, ED can sometimes appear before other symptoms of cardiovascular disease.
Diabetes and metabolic health
Diabetes and insulin resistance can damage blood vessels and nerves involved in erections. Excess weight and metabolic syndrome may also contribute.
Hormonal changes
Low testosterone can contribute to reduced sexual desire and may affect erectile function. However, testosterone is not the only cause of ED, and testosterone treatment is not appropriate for every man experiencing erectile difficulties.
Medications and lifestyle factors
Certain prescription medications, tobacco use, excessive alcohol consumption, poor sleep, and limited physical activity may contribute to ED.
Psychological factors
Stress, anxiety, depression, and relationship concerns can affect sexual function. Psychological factors can occur independently or alongside physical causes.
Erectile Dysfunction Treatment in Florida: Why Identifying the Cause Matters
Effective erectile dysfunction treatment in Florida starts with understanding the underlying cause. An evaluation should include a review of medical history, medications, sexual health, and cardiovascular risk factors.
The American Urological Association recognizes ED as a potential marker of underlying cardiovascular disease. New or persistent ED should not automatically be treated as an isolated sexual health problem.
Medication Options for Erectile Dysfunction
Several medications may be used to address erectile dysfunction. They do not all work the same way, and the appropriate option depends on the individual's health history and clinical evaluation.
Sildenafil
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor. It helps relax smooth muscle and increase blood flow into the penis during sexual stimulation. It is one of the most commonly used medications for ED.
Tadalafil
Tadalafil is also a PDE5 inhibitor. It improves blood flow to the penis in response to sexual stimulation. It has a longer duration of action than sildenafil, which provides a different degree of flexibility for some patients.
Oxytocin
Oxytocin is a naturally occurring hormone involved in several processes, including social bonding and sexual response. It has been studied for potential effects on sexual function, but it is not an established or FDA-approved treatment for erectile dysfunction. Evidence supporting its use in compounded ED formulations remains limited.
Bremelanotide (PT-141)
Bremelanotide, also known as PT-141, acts on melanocortin receptors involved in sexual desire and arousal. The FDA-approved product, Vyleesi, is indicated for a specific form of acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. It is not FDA-approved to treat erectile dysfunction in men. Compounded formulations are not equivalent to the FDA-approved product.
Medication Formulations Available Through Apex Coastal Wellness
Depending on clinical evaluation and individual circumstances, medication options may include:
Sildenafil: A conventional medication option that supports penile blood flow.
Tadalafil: A conventional medication option that supports penile blood flow and has a longer duration of action.
Tadalafil / Sildenafil: A compounded combination containing two PDE5 inhibitors. Combining these medications is not a routine guideline-based approach and requires careful clinical consideration.
Oxytocin / Sildenafil: A compounded combination pairing a medication that supports penile blood flow with oxytocin, which has been studied for potential effects on sexual response.
Oxytocin / Tadalafil / Sildenafil: A compounded combination containing oxytocin and two PDE5 inhibitors. Evidence for this combination is limited, and it is not a standard first-line ED treatment.
Tadalafil / Oxytocin / PT-141: A compounded combination containing a PDE5 inhibitor, oxytocin, and bremelanotide. Evidence supporting this combination for ED is limited.
Important information about compounded medications: Compounded drugs are not FDA-approved. The FDA does not verify their safety, effectiveness, or quality before they are marketed. Compounded medications may be appropriate in certain circumstances, but they should be considered individually after discussing their potential benefits, limitations, and risks.
PDE5 inhibitors such as sildenafil and tadalafil must not be used with nitrate medications. Combining ED medications or using multiple PDE5 inhibitors can increase the risk of adverse effects and should only be considered under appropriate medical supervision.
Jeff Schnur, MSN, APRN, FNP-BC
Apex Coastal Wellness
Outlast the Day.
References
Burnett AL, et al. Erectile Dysfunction: AUA Guideline. The Journal of Urology. 2018;200(3):633–641.
European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction. 2025.
U.S. Food and Drug Administration. Compounding and FDA-approved drug information.
U.S. Food and Drug Administration. Vyleesi (bremelanotide) prescribing information.
